文献速递糖尿病

糖尿病患者报告结局:测量什么以及如何测量?一篇叙述性综述

Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review.
PubMed 文献 · Diabetologia · 2023-05-24

患者报告结局(PRO)有助于共享决策和研究,患者报告结局测量工具(PROM)是测量PRO的问卷。本叙述性综述基于PRO概念框架,建议糖尿病患者应测量疾病特异性症状、一般症状、功能状态、总体健康感知和总体生活质量,并推荐使用通用PROM(如SF-36、WHODAS 2.0或PROMIS)辅以疾病特异性PROM;现有糖尿病特异性PROM量表均未充分验证,但DSSCI、DDS和PAID显示足够内容效度。

要点

  • 建议糖尿病患者测量疾病特异性症状、一般症状、功能状态、总体健康感知和总体生活质量。
  • 可考虑使用SF-36、WHODAS 2.0或PROMIS等通用PROM,必要时补充疾病特异性PROM。
  • 现有糖尿病特异性PROM量表均未充分验证,但DSSCI、DDS和PAID显示足够内容效度。

核心结论

  • 建议对糖尿病患者测量疾病特异性症状、一般症状、功能状态、总体健康感知和总体生活质量。
  • 可考虑使用通用PROM(如SF-36、WHODAS 2.0或PROMIS)测量常见相关PRO,必要时补充疾病特异性PROM。
  • 现有糖尿病特异性PROM量表均未充分验证,但DSSCI、DDS和PAID显示足够内容效度。
  • 推荐进一步验证具有足够内容效度的糖尿病特异性PROM,并考虑基于项目反应理论开发的通用条目库测量常见相关PRO。

研究设计与样本

  • 叙述性综述,基于PRO通用概念框架提出建议。

主要发现

  • 在研究和临床实践中使用不同的PROM(部分通用、部分疾病特异性),测量许多不同内容,威胁糖尿病领域研究和临床发现的效度。
  • 现有糖尿病特异性PROM量表均未充分验证,但DSSCI测量糖尿病特异性症状、DDS和PAID测量痛苦显示足够内容效度。

关键数值与推荐

  • 建议测量的PRO:疾病特异性症状(如对低血糖的担忧和糖尿病痛苦)、一般症状(如疲劳和抑郁)、功能状态、总体健康感知和总体生活质量。
  • 可考虑的通用PROM:36条目简短健康调查(SF-36)、WHO残疾评定方案(WHODAS 2.0)或患者报告结局测量信息系统(PROMIS)。
  • 显示足够内容效度的糖尿病特异性PROM:糖尿病症状自我照护量表(DSSCI)用于测量糖尿病特异性症状,糖尿病痛苦量表(DDS)和糖尿病问题区域(PAID)用于测量痛苦。

临床怎么用

  • 标准化使用相关PRO和心理测量学可靠的PROM可帮助告知糖尿病患者预期疾病和治疗过程,用于共享决策、监测结局和改善医疗保健。

局限性

  • 现有糖尿病特异性PROM量表均未充分验证。
  • 推荐进一步验证具有足够内容效度的糖尿病特异性PROM,并考虑基于项目反应理论开发的通用条目库。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patient-reported outcomes (PROs) are valuable for shared decision making and research. Patient-reported outcome measures (PROMs) are questionnaires used to measure PROs, such as health-related quality of life (HRQL). Although core outcome sets for trials and clinical practice have been developed separately, they, as well as other initiatives, recommend different PROs and PROMs. In research and clinical practice, different PROMs are used (some generic, some disease-specific), which measure many different things. This is a threat to the validity of research and clinical findings in the field of diabetes. In this narrative review, we aim to provide recommendations for the selection of relevant PROs and psychometrically sound PROMs for people with diabetes for use in clinical practice and research. Based on a general conceptual framework of PROs, we suggest that relevant PROs to measure in people with diabetes are: disease-specific symptoms (e.g. worries about hypoglycaemia and diabetes distress), general symptoms (e.g. fatigue and depression), functional status, general health perceptions and overall quality of life. Generic PROMs such as the 36-Item Short Form Health Survey (SF-36), WHO Disability Assessment Schedule (WHODAS 2.0), or Patient-Reported Outcomes Measurement Information System (PROMIS) measures could be considered to measure commonly relevant PROs, supplemented with disease-specific PROMs where needed. However, none of the existing diabetes-specific PROM scales has been sufficiently validated, although the Diabetes Symptom Self-Care Inventory (DSSCI) for measuring diabetes-specific symptoms and the Diabetes Distress Scale (DDS) and Problem Areas in Diabetes (PAID) for measuring distress showed sufficient content validity. Standardisation and use of relevant PROs and psychometrically sound PROMs can help inform people with diabetes about the expected course of disease and treatment, for shared decision making, to monitor outcomes and to improve healthcare. We recommend further validation studies of diabetes-specific PROMs that have sufficient content validity for measuring disease-specific symptoms and consider generic item banks developed based on item response theory for measuring commonly relevant PROs.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Terwee CB, Elders PJM, Blom MT, et al. Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review. Diabetologia. 2023. PMID: 37222772. doi:10.1007/s00125-023-05926-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。